Inguinal Hernia Treatment: Stationary/Inpatient vs. Ambulatory/Outpatient Setting - HerStAmb Study
NCT ID: NCT05234242
Last Updated: 2022-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
237 participants
OBSERVATIONAL
2019-01-01
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this prospective, non-randomized, multicenter study was to compare the outcome of outpatient/ambulatory and inpatient/stationary postoperative care by examining the re-admission rate, complication rate and quality of life in patients with primary unilateral inguinal hernia repair.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Should Prosthetic Repair of Incisional Abdominal Hernias be Drain or Not?
NCT00478348
Functional Outcome After Groin Hernia Mesh Repair: Open Versus Laparoscopy
NCT00625534
Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men
NCT00263250
Robotic vs. Conventional Minimal-invasive Inguinal Hernia Repair
NCT05216276
Prophylactic Mesh Implantation for the Prevention of Incisional Hernia
NCT01203553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While there is a growing trend towards day surgery, considerable variations exist internationally and between hospitals at the national level. The evaluation of the French hernia register by Drissi et al showed slightly lower re-admission rate in ambulatory patients while Steger et al report a positive experience as well as acceptance of the ambulatory TEP procedure in one centre in Germany. Köckerling et al showed no significant differences in pain and recurrence rate in primary elective unilateral inguinal hernia treated in the outpatient setting. However, there are no prospective studies and data comparing outpatient/ambulatory vs. inpatient/stationary treatment setting in respect of complications, re-admission rate and patient outcome/quality of life.
Since 01/2018, AVOS (ambulant vor stationär = ambulatory to stationary) regulation has been progressively implemented in Swiss hospitals for certain procedures - inguinal hernia treatment included. AVOS regulation passed into law in 01/2019, with small modifications made to the recommendations of the European Hernia Society for hernia treatment in the outpatient setting.
Our study is the first prospective study comparing the efficiency and the effectiveness of ambulatory/outpatient and stationary/inpatient postoperative management through the investigation of the postoperative re-admission rate, complication rate and patient outcome/quality of life after the procedure in a group of patients with primary unilateral inguinal hernia.
The study was designed as a prospective non-randomized multicentre study carried out at 2 Swiss hospitals (Centre A: Triemli City Hospital, Centre B: Cantonal Hospital Schaffhausen) between 01/2019 - 04/2020 following the same study protocol. All patients were seen preoperatively in an outpatient clinic or emergency room. Patients were examined by a surgeon and anesthesiologist and after evaluation of the objective status, comorbidities and social situation, the procedure and postoperative management according to the AVOS guidelines were decided. Patients with a recurrent or bilateral hernia were excluded as they could bias the re-admission rate as the complication rate and need for analgesia are higher in these patients. The primary endpoint of the study was re-admission rate within 6 weeks postoperatively due to complication (a: seroma, b: hematoma, c: wound infection/dehiscence, d: recurrence, e: pain, f: postop. delirium). Secondary endpoints were the complication rate and patient outcome at 6 weeks postoperatively measured by the SF-36 questionnaire, a well-established tool for measuring the performance status and quality of life of patients in 8 different categories.
Intention-to-treat analysis was done and descriptive statistics using the chi-square test for categorical variables was used to measure the relationship between treatment setting and complication rate as well as treatment setting and re-admission rate. Per protocol analysis with an independent t-test was used to find any significant difference between the treatment setting and mean clinical outcome of the patients measured by SF-36 at 6 weeks postoperatively. P \< 0.05 was statistically significant. The study was approved by the Ethics Committee of Zürich (Kantonale Ethikkomission Zürich, BASEC Nr. 2018-10832)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stationary/inpatient
inguinal hernia repair
inguinal hernia repair performed either in stationary/inpatient or ambulatory/outpatient setting
ambulatory/outpatient
inguinal hernia repair
inguinal hernia repair performed either in stationary/inpatient or ambulatory/outpatient setting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inguinal hernia repair
inguinal hernia repair performed either in stationary/inpatient or ambulatory/outpatient setting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Written informed consent after participants' information,
3. Outpatient or inpatient treatment
Exclusion Criteria
2. Bilateral hernia
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Michal Ziga
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Michal Ziga
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michal Ziga, Dr.
Role: PRINCIPAL_INVESTIGATOR
Cantonal Hospital Schaffhausen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cantonal Hospital Schaffhausen
Schaffhausen, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ziga M, Burla L, Imhof A, Gurtler T, Weber M. Inguinal hernia treatment in Switzerland: inpatient vs. outpatient setting - HerStAmb Study (prospective observational two-centre comparative study). Langenbecks Arch Surg. 2023 Jan 9;408(1):14. doi: 10.1007/s00423-023-02766-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HerStAmb Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.